RT Journal Article
SR Electronic
T1 Characterization of the indoor near-field and far-field aerosol transmission in a model commercial office building
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.25.21252239
DO 10.1101/2021.02.25.21252239
A1 Chih-Hsiang Chien
A1 Mengdawn Cheng
A1 Im Piljae
A1 Kashif Nawaz
A1 Brian Fricke
A1 Anthony Armstrong
YR 2021
UL http://medrxiv.org/content/early/2021/03/01/2021.02.25.21252239.abstract
AB To simulate the exposure potential of infectious aerosol such as SARS-CoV-2 in an office building setting, experimental studies for airborne particle transmission have been conducted in a model commercial office building at the Oak Ridge National Laboratory. The synthetic test aerosol particles had diameters similar to that of viral particles, in the nanometer size range of genetic fragments. Thus, the test aerosol provided a realistic representation of SARS-CoV-2 viral particle transmission. The study results, which are still being analyzed carefully at the present, suggest that in a door-closed single room setting, the heating, ventilating, and air-conditioning (HVAC) system can facilitate aerosol transmission, and 10 measuring points in a single room report the normalized concentration ranged from 0.45 – 0.66. Additionally, at a measuring point 6 feet away from the source, the aerosol concentration can reach a plateau normalized concentration of about 0.6 within 30 minutes. When interior doors were closed, aerosol particle transmission into adjacent rooms occurred through the building HVAC system, at a lower rate compared to the open-door scenario. If the interior doors were open, however, then the transmission into adjacent rooms depends on building indoor air movement and distance from the source. The building HVAC system provided an approximately less than 10% aerosol transmission rate, while transmission through a door opening can add up to 40% of transmission into adjacent rooms from the source location.Footnote This manuscript has been authored by UT-Battelle, LLC, under contract DE-AC05-00OR22725 with the US Department of Energy (DOE). The US government retains and the publisher, by accepting the article for publication, acknowledges that the US government retains a nonexclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this manuscript, or allow others to do so, for US government purposes. DOE will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the Department of Energy/Office of Energy Efficiency and Renewable Energy Research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study does not require IRB/ethics committee approvals.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript.